✦ LIBER ✦

Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction

✍ Scribed by Nicholas W. Choong; Ann M. Mauer; Daniel C. Haraf; Mark K. Ferguson; Alan B. Sandler; Kenneth A. Kesler; Paul A. S. Fishkin; Rafat H. Ansari; James Wade; Stuart A. Krauss; David F. Sciortino; Mitchell C. Posner; Masha Kocherginsky; Philip C. Hoffman; Livia Szeto; Everett E. Vokes

Book ID: 107577273
Publisher: Springer US
Year: 2010
Tongue: English
Weight: 353 KB
Volume: 28
Category: Article
ISSN: 1357-0560
DOI: 10.1007/s12032-010-9658-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of induction carboplati

A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma

✍ Lim, Annette M.; Corry, June; Collins, Marnie; Peters, Lester; Hicks, Rodney J.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 278 KB

High dose chemoradiotherapy followed by

High dose chemoradiotherapy followed by esophagectomy for adenocarcinoma of the esophagus and gastroesophageal junction : Results of a Phase II study of the Eastern Cooperative Oncology Group

✍ Steven M. Keller; Louise M. Ryan; Lawrence R. Coia; Phuong Dang; David J. Vaught 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## BACKGROUND. To assess the toxicity, local response, and survival associated with multimodality therapy in a cooperative group setting, patients with biopsy-proven clinical Stage I or II adenocarcinoma of the esophagus (staged according to 1983 American Joint Committee on Cancer criteria) or gast

Induction Chemo-Radiotherapy for Squamou

Induction Chemo-Radiotherapy for Squamous Cell Carcinoma of the Thoracic Esophagus: Long-Term Results of a Phase II Study

✍ Ernesto Laterza; Giovanni de’ Manzoni; Pietro Tedesco; Alfredo Guglielmi; Giusep 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 70 KB

Paclitaxel and Cisplatin in Advanced or

Paclitaxel and Cisplatin in Advanced or Recurrent Carcinoma of the Endometrium: Long-Term Results of a Phase II Multicenter Study

✍ Meletios A. Dimopoulos; Christos A. Papadimitriou; Vassilis Georgoulias; Lia A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Docetaxel plus epidoxorubicin as neoadju

Docetaxel plus epidoxorubicin as neoadjuvant treatment in patients with large operable or locally advanced carcinoma of the breast : A single-center, Phase II study

✍ Andrea de Matteis; Francesco Nuzzo; Giuseppe D'Aiuto; Vincenzo Labonia; Gabriell 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 76 KB 👁 1 views

## Abstract ## BACKGROUND The objective of this study was to test the activity and toxicity of epirubicin plus docetaxel as primary chemotherapy for women with large, operable (T2; > 3 cm) or locally advanced (Stage III) breast carcinoma, including patients with inflammatory breast carcinoma. ##

Phase II Study of Concurrent Chemoradiat

Phase II Study of Concurrent Chemoradiation with Bevacizumab and Docetaxel for Treatment of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN)

✍ N. Galanopoulos; M. Yao; P. Lavertu; A. Argiris; J. Greskovich; P. Fu; J. Wasman 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 40 KB